P3 Health Partners Inc. Announces Approximately $42.2 Million Private Placement
P3 Health Partners Inc. (Nasdaq: PIII), a patient- centered and physician-led population health management company (the “Company”), today announced that it has entered into definitive agreements to sell securities in a private placement with certain institutional investors.
- P3 Health Partners Inc. (Nasdaq: PIII), a patient- centered and physician-led population health management company (the “Company”), today announced that it has entered into definitive agreements to sell securities in a private placement with certain institutional investors.
- The lead institutional investors in the private placement are affiliates of Chicago Pacific Founders (“CPF”).
- The transaction is expected to result in gross proceeds of approximately $42.2 million, including approximately $20.0 million of gross proceeds from purchases by affiliates of CPF, before deducting placement agent fees and offering expenses.
- The closing of the private placement is subject to certain conditions and is expected to occur on or about May 24, 2024.